Login/Sign Up
₹31570*
MRP ₹38500
18% off
₹32725*
MRP ₹38500
15% CB
₹5775 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
About Tocira-400 Infusion
Tocira-400 Infusion belongs to the class of 'immunosuppressants', primarily used to treat rheumatoid arthritis, ankylosing spondylitis, and giant cell arteritis (inflammation of the lining of your arteries) in adults. It is also used to treat rheumatoid arthritis in children, such as systemic juvenile idiopathic arthritis (SJIA) and polyarticular juvenile idiopathic arthritis (PJIA). Rheumatoid arthritis is an autoimmune disease in which the body's immune system attacks its own cells and cause joint pain with inflammation. Tocira-400 Infusion is currently being trialled to treat breathing complications in COVID-19 (Corona Virus Disease-19) patients.
Tocira-400 Infusion consists of 'Tocilizumab' that belongs to the class of 'interleukin inhibitors.' It works by blocking the Interleukin-6 (IL-6), a substance released by the body that causes inflammation. Lately, Tocira-400 Infusion is also being used in COVID-19 infection to reduce the severity of inflammation and damage in the lungs. It is thought to decrease the cytokine storm, an excessive immune response that occurs in the lungs of a COVID-19 infected person.
Your doctor will decide the dose and duration based on the medical condition. Common side effects of Tocira-400 Infusion include runny nose, sinus pain, sore throat, increased blood pressure, pain and swelling at the injection site, and headache. These side effects are not familiar to everyone and vary individually. However, if the side effects are persistent, please reach out to your doctor.
Before starting Tocira-400 Infusion, inform your doctor if you have any liver, heart or kidney diseases, stomach and intestinal ulcers, multiple sclerosis (nerve and muscle disease), diabetes, weak immune system (HIV), hepatitis B, cancer, and active infections. Let your doctor know if you are pregnant or breastfeeding before starting Tocira-400 Infusion. Tocira-400 Infusion may cause dizziness, so drive only if you are alert and focused. Tocira-400 Infusion should not be given to children under two years of age as safety has not been established. Avoid consuming alcohol along with Tocira-400 Infusion as it could lead to increased dizziness and risk of liver damage.
Uses of Tocira-400 Infusion
Directions for Use
Medicinal Benefits
Tocira-400 Infusion treats pain, redness, and inflammation (swelling) in patients with rheumatoid arthritis, ankylosing spondylitis, and giant cell arteritis. It contains 'Tocilizumab,' an 'interleukin inhibitor.' It works by blocking the Interleukin-6 (IL-6), a substance released by the body that causes inflammation. Lately, Tocira-400 Infusion is also being used in COVID-19 infection to reduce breathing complications, the severity of inflammation, and damage in the lungs. It is used to decrease the cytokine storm, an excessive immune response that occurs in the lungs of a COVID-19 infected person.
How Tocira-400 Infusion Works
Storage
What if I have taken an overdose of Tocira-400 Infusion
Drug Warnings
Inform your doctor if you have any liver, heart or kidney diseases, stomach and intestinal ulcers (diverticulitis), multiple sclerosis (nerve and muscle disease), low blood cell count, diabetes, weak immune system (HIV), hepatitis B, cancer, and active infections before starting Tocira-400 Infusion. Avoid close contact with people who have infections like chickenpox, measles, tuberculosis, and flu that can be easily spread. Thoroughly wash your hands to prevent the spread of infection. Do not take live vaccines while being treated with Tocira-400 Infusion to prevent any serious consequences. Tocira-400 Infusion may cause dizziness and drowsiness, so drive only if you are alert and focused. Avoid consuming alcohol along with Tocira-400 Infusion as it could lead to increased dizziness and risk of stomach bleeding/ulcers. Tocira-400 Infusion is not recommended in children younger than two years of age as safety and efficacy is not established. Store Tocira-400 Infusion at temperatures of 2°C to 8°C. Do not freeze the vial.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
You are recommended to avoid alcohol consumption if you are being treated with Tocira-400 Infusion. Alcohol intake, along with Tocira-400 Infusion, may cause increased dizziness and risk of stomach bleeding/ulcers.
Pregnancy
Caution
Tocira-400 Infusion is a pregnancy category C drug and is not recommended during pregnancy since animal studies showed harmful effects on the developing baby. Your doctor will prescribe Tocira-400 Infusion only if the benefit outweighs the risk.
Breast Feeding
Caution
It is not known if Tocira-400 Infusion passes into the breastmilk when used by breastfeeding mother. Your doctor will prescribe Tocira-400 Infusion only if the benefit outweighs the risk.
Driving
Unsafe
Tocira-400 Infusion may make you feel dizzy and sleepy. Do not drive or operate machinery if you experience dizziness or drowsiness.
Liver
Caution
Please consult your doctor since Tocira-400 Infusion should be used with caution in patients with liver impairment/liver disease. Dose adjustment may be needed in patients with liver impairment. However, Tocira-400 Infusion is not recommended in patients with active liver diseases.
Kidney
Caution
Please consult your doctor since Tocira-400 Infusion should be used with caution in patients with kidney impairment/kidney disease. Dose adjustment may be required.
Children
Caution
Tocira-400 Infusion is not recommended in children younger than two years of age.
Have a query?
Tocira-400 Infusion contains Tocilizumab, an immunosuppressant. It blocks the action of Interleukin-6 (IL-6), a substance released by the body that causes inflammation. Thus, it helps in decreasing pain and inflammation in various diseases like rheumatoid arthritis, ankylosing spondylitis, and giant cell arteritis.
When a person is infected with the coronavirus, his/her immune system responds in such a way that it sends useful immune chemicals to the affected areas of the lungs to fight the infection. However, in some people, this release of immune chemicals is overactive, resulting in a cytokine storm, an excessive immune response in the lungs. This can further lead to severe breathing complications in an infected person. Tocira-400 Infusion reduces this cytokine storm and further prevents the inflammation and damage in the lungs of a COVID-19 infected person.
Though Tocilizumab in Tocira-400 Infusion is under the clinical trial stage of development by FDA for being used in COVID-19 infection, it is currently used to treat breathing complications for COVID-19 patients. It is known to show improvement in pneumonia during coronavirus infection.
Tocira-400 Infusion is not recommended for every person infected with the coronavirus. Tocira-400 Infusion has potential hazards and is only prescribed by doctors in patients with severe breathing difficulties and who have highly dropping saturation levels (blood oxygen level (SpO2)).
Tocira-400 Infusion is to be carefully administered with caution in patients under doctor's supervision only since it can cause potential side effects like elevated liver enzymes, neutropenia (low levels of neutrophils), and thrombocytopenia (low levels of platelets). It can also cause serious viral infections like hepatitis B, bacterial infections including active tuberculosis, and fungal infections including candidiasis, aspergillosis, and pneumocystis.
Tocira-400 Infusion affects your immune system and makes you more susceptible to infections. Hence, it is not recommended in people with active infections like tuberculosis, hepatitis B, abnormal liver enzymes, and platelet counts less than 50,000. Tocira-400 Infusion can also increase the risk of developing cancers; hence it is essential to mention your doctor if you had a history of any cancer.
Even if there is no improvement after administering Tocira-400 Infusion, your doctor may suggest an alternate course. Please note that Tocira-400 Infusion does not reverse the damage caused due to coronavirus infection, but it will further prevent the inflammation of the lungs. It is also advised to medically examine for other lung and heart related dysfunctions even the patient suffers breathlessness after Tocira-400 Infusion administration.
It is not recommended to get live vaccines like measles, mumps, rubella (MMR), polio, rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine while being treated with Tocira-400 Infusion. This could lead to a severe infection. Please consult a doctor before you start Tocira-400 Infusion if you are undergoing any vaccinations.
The common side effects of the Tocira-400 Infusion are headache, runny nose or sneezing, redness, itching, pain, or swelling in the place where injected, constipation, diarrhea, and Increased blood pressure. However, these symptoms vanish as your body adjusts to the medication. If these symptoms become worse, please consult a doctor for relief.
If you have stomach or intestinal ulcers (diverticulitis), inform your doctor before receiving Tocira-400 Infusion. Your doctor will assess your condition and determine whether Tocira-400 Infusion is safe for you, adjusting the dosage if necessary to minimize risks and ensure effective treatment.
Tocira-400 Infusion is a versatile medication that can help manage various conditions. It's used to treat adults with rheumatoid arthritis, ankylosing spondylitis, and giant cell arteritis. Children with systemic juvenile idiopathic arthritis (SJIA) and polyarticular juvenile idiopathic arthritis (PJIA) can also benefit from Tocira-400 Infusion. Additionally, hospitalized adults with COVID-19 may be treated with Tocira-400 Infusion to manage breathing complications and reduce the risk of respiratory failure. However, it's crucial to note that Tocira-400 Infusion should only be used under the guidance and supervision of a qualified healthcare professional, who will determine the appropriate treatment course based on individual patient needs and circumstances.
Tocira-400 Infusion is not recommended for all COVID-19 patients. It is typically reserved for hospitalized patients with severe COVID-19 who are receiving corticosteroids and require supplemental oxygen or mechanical ventilation. This is because the medication can have significant side effects and should be administered under close medical supervision in a monitored clinical setting.
If Tocira-400 Infusion doesn't work after the first dose, your healthcare provider may recommend up to three additional doses, spaced at least 8 hours apart. However, if your symptoms persist or worsen, seek immediate medical attention for further evaluation and alternative treatments. Remember, never take an overdose or stop treatment without consulting your doctor, as this can have serious consequences.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.
We provide you with authentic, trustworthy and relevant information